Abstract:Gastrointestinal cancer (GIC) is a group of malignant tumors, including esophagus, stomach, liver, pancreas, as well as colorectal region. GIC accounts for more than 27% of the total newly diagnosed tumors worldwide, and 37% of tumor-related death events among all types of tumors. Totally, about 4.8 million new cases are yearly diagnosed and 3.4 million people lost their lives due to those malignancies every year (1). Moreover, the amount of either new or death cases are predicted to increase by 58% and 73% to 7.5 million and 5.6 million by 2040 due to the changes in the age composition and growth of the world population (2). In fact, the current poor prognosis and high mortality rate of GIC is mainly due to a high risk of metastasis, with its occurrence accompanied by lymphatic metastases and distant metastases (3–5). This serious pending burden forces us to reconsider how we deal with this challenge. In purpose of averting many future diagnoses and deaths, it is necessary to dedicate more work to the fundamental studies of these diseases, seeking reliable biomarkers benefiting to early diagnosis and preventative actions, and the development of innovative treatment strategies (6–9). The Research Topic of this special issue takes an in-depth look at novel molecular mechanisms for gastrointestinal tumorigenesis and metastasis, as well as report the latest progress related to new biomarkers, therapeutic targets and development of new treatment strategies which will contribute to improved therapeutic efficacy and prognosis for GIC patients. A collection of original articles, systematic reviews, case reports and perspectives will provide readers with news on exciting breakthroughs in research into GICs including gastric cancer (GC), hepatocellular carcinoma (HCC), Cholangiocarcinoma (CCA), pancreatic ductal adenocarcinoma (PDAC), and colorectal cancer (CRC). The majority of early stage of GIC metastases cannot be detected by computed tomography (CT), magnetic resonance imaging (MRI) or other traditionally morphological imaging approaches since the lesions are too small or they have not yet formed cancer nodules (10). However, there is still a rather limited number of useful biomarkers available that represents the risk of misdiagnosis leading to an ineffective therapeutic strategy and substantial problem for the management of GIC. Next generation sequencing (NGS) technology would appear to be a promising tool for GIC diagnosis. Chenming Wang et al. utilized on NGS RNA-based approaches to seek the significant regulators for liver metastases in colorectal cancer (CRC) patients. In their study, the elevated

Research and Clinical Applications of Molecular Biomarkers in Gastrointestinal Carcinoma (Review)

Emerging Molecular Basis of Hematogenous Metastasis in Gastric Cancer

Epigenetic Biomarkers: Potential Applications in Gastrointestinal Cancers.

Current and future molecular diagnostics of gastric cancer

MicroRNAs: novel biomarkers for gastrointestinal carcinomas

Intratumoral Microbiota: Metabolic Influences and Biomarker Potential in Gastrointestinal Cancer

Advances in Epigenetic Biomarker Research in Colorectal Cancer.

Current And Potential Biomarkers In Gastric Cancer: A Critical Review Of The Literature

Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer

Editorial: Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment

Effects Of Molecular Markers On The Treatment Decision And Prognosis Of Colorectal Cancer: A Narrative Review

Gastrointestinal Malignancy: Genetic Implications to Clinical Applications

Progress and prospects of biomarker-based targeted therapy and immune checkpoint inhibitors in advanced gastric cancer

Molecular alterations and clinical relevance in cervical carcinoma and precursors (Review)

Effects of Molecular Markers on the Treatment Decision and Prognosis of Colorectal Cancer: a Narrative Review.

Molecular aspects in the diagnosis of gastric cancer

[Molecular Markers of Gastrointestinal Tumors and Individualized Treatment].

Prognostic Biomarker in Advanced Gastric Cancer

Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers

The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice

Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies